Primary |
Drug Use For Unknown Indication |
68.4% |
Blood Cholesterol Increased |
10.5% |
Low Density Lipoprotein Increased |
10.5% |
Hypercholesterolaemia |
5.3% |
Hypertriglyceridaemia |
5.3% |
|
Renal Failure Acute |
64.7% |
White Blood Cell Count Decreased |
11.8% |
Muscular Weakness |
5.9% |
Myalgia |
5.9% |
Stent Placement |
5.9% |
Yellow Skin |
5.9% |
|
Secondary |
Back Pain |
22.2% |
Hypertension |
22.2% |
Pain |
22.2% |
Anticoagulant Therapy |
11.1% |
Blood Cholesterol |
11.1% |
Polyuria |
11.1% |
|
Medication Error |
40.0% |
Hepatic Function Abnormal |
20.0% |
Nasopharyngitis |
20.0% |
Trigger Finger |
20.0% |
|
Concomitant |
Product Used For Unknown Indication |
49.5% |
Blood Cholesterol Increased |
8.3% |
Drug Use For Unknown Indication |
8.0% |
Hypertension |
6.1% |
Blood Triglycerides Increased |
3.4% |
Type 2 Diabetes Mellitus |
3.2% |
Diabetes Mellitus |
2.6% |
Hyperlipidaemia |
2.1% |
Chronic Obstructive Pulmonary Disease |
1.9% |
Prophylaxis |
1.9% |
Arrhythmia |
1.6% |
High Density Lipoprotein Decreased |
1.6% |
Cough |
1.4% |
Glaucoma |
1.4% |
Gastrooesophageal Reflux Disease |
1.3% |
Hiv Infection |
1.3% |
Vitamin Supplementation |
1.3% |
Blood Cholesterol |
1.1% |
Cardiac Disorder |
1.1% |
Anaemia |
1.0% |
|
Flushing |
10.1% |
Wound Infection Staphylococcal |
10.1% |
Vomiting |
8.7% |
Pruritus |
7.2% |
Dyspnoea |
5.8% |
Electrocardiogram Qt Prolonged |
5.8% |
Erythema |
5.8% |
Headache |
4.3% |
Myocardial Infarction |
4.3% |
Nausea |
4.3% |
Pain In Extremity |
4.3% |
Paraesthesia |
4.3% |
Rash |
4.3% |
Coronary Artery Disease |
2.9% |
Death |
2.9% |
Drug Ineffective |
2.9% |
Fatigue |
2.9% |
Gynaecomastia |
2.9% |
Muscle Spasms |
2.9% |
Oxygen Supplementation |
2.9% |
|